Navigation Links
Silence Therapeutics Patent Update
Date:7/30/2008

ed to commercialize the truly novel delivery systems that the two partners develop together.

In July 2007, Silence Therapeutics formed its first research and development collaboration with AstraZeneca to develop novel AtuRNAi therapeutics against five specific targets, including those in respiratory indications. This collaboration was the first industry validation of the potential application of Silence Therapeutics' proprietary AtuRNAi molecules and solidified the Company's leadership position in field of RNAi therapeutics.

The Company's AtuRNAi technology also has been sublicensed to Pfizer via Quark's license to them of the compound RTP-801i-14 for the treatment of age-related macular degeneration (AMD) and a number of other indications. This compound entered the clinic in early 2007. Silence Therapeutics also has licensed to Quark rights to the AtuRNAi structure for Quark's proprietary compound, AKIi-5, which is in a Phase I human clinical study for treatment of acute kidney injury.

Silence Therapeutics is based in London, UK, and Berlin, Germany, and is listed on AIM.

About RNAi

RNA interference (RNAi), is a Nobel Prize winning technology and one of the most exciting areas of drug discovery today. It represents a completely new approach to selectively 'silence' or inactivate disease relevant genes and as such it has the potential to create a new class of therapeutic products. RNAi could therefore offer a therapeutic approach to a broad range of diseases (cancer, infectious diseases, inherited diseases), many of which have been regarded as incurable and are not addressed by current therapeutics, therefore providing a large market opportunity.

Forward-Looking Statements

This press release includes forward-looking statements that are subject to risks, uncertainties and other factors. These risks and uncertainties could cause actual results to differ materially from those referred to in the forward-looking statements
'/>"/>

SOURCE Silence Therapeutics plc
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Silence Obtains Important Patent Protection for Lead Internal Development Compound, Atu027
2. Organizational Changes at Silence Therapeutics
3. Silence Therapeutics Announces Successful Opposition of Glover Patent
4. FDA Approves Quark IND for DGFi, an siRNA Therapeutic Based on Silence Therapeutics Unique Proprietary Chemistry
5. Silence Therapeutics and AstraZeneca Announce Collaboration to Develop Novel Approaches for siRNA Drug Delivery
6. OREXIGEN(R) Therapeutics Receives Notice of Allowance for U.S. Patent Covering the Composition of Matter in OREX-003
7. Zenobia Therapeutics, Inc. Receives Michael J. Fox Foundation for Parkinsons Research Award for Work on PD-implicated Protein LRRK2
8. Cara Therapeutics Secures $12.3 Million in Series C Extension Financing
9. United Therapeutics to Announce Second Quarter 2008 Financial Results Before Market Open on Thursday, July 31, 2008
10. Cell Therapeutics, Inc. Announces Single Institutional Investor to Purchase $44.5 Million of Units Consisting of Senior Convertible Notes and Warrants
11. Duska Therapeutics Submits Phase 3 ATPace(TM) Protocol to FDA for Comment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... Pittcon is pleased to announce that the 2015 ... Scientific, have organized a session on nanotechnology for presentation ... Asia’s largest analytical and scientific instruments show, will be ... , The four speakers in this U.S. symposium, “Thinking ... Single Cells” will present their use of nanotechnology to ...
(Date:8/29/2014)... Hills, NY (PRWEB) August 29, 2014 ... Burnt Hills Veterinary Hospital are seeking candidates to participate ... dogs with osteoarthritis. The ultimate goal of this ... donor stem cells into one or two arthritically affected ... treated joints. , Candidates for the current investigational ...
(Date:8/29/2014)... August 29, 2014 Due to a misstatement ... week, the Adult Stem Cell Technology Center, LLC ( ASCTC ... stem cell therapy research that might benefit ALS patients. ... for new stem cell technologies and therapeutic applications, FRC listed ... Bucket Challenge donors who wish not to support research ...
(Date:8/29/2014)... Boston, MA, San Antonio, TX (PRWEB) August 29, ... audited, ISO 9001:2008 and ISO 13485:2003 certified, GAMP® ... it has been awarded an international Phase II ... patients with non-Hodgkin’s lymphoma. , Throughout this trial, ... services including, but not limited to, protocol and ...
Breaking Biology Technology:Fifth Annual U.S. Symposium at JASIS Organized by Pittcon’s Program Chairman Hub MacDonald 2Burnt Hills Veterinary Hospital Seeks Candidates for an Investigational Study of Stem Cells for Dogs with Arthritis 2The Adult Stem Cell Technology Center, LLC Declines ALS Ice Bucket Challenge Donors Wishing to Support Ethical Research for New Stem Cell Therapies 2The Adult Stem Cell Technology Center, LLC Declines ALS Ice Bucket Challenge Donors Wishing to Support Ethical Research for New Stem Cell Therapies 3Intrinsic Imaging Awarded Phase II Clinical Trial to Assess New Treatment for Non-Hodgkin’s Lymphoma 2
... May 14 StemCor Systems, Inc., a,medical device ... today that it has been awarded a,National Institutes ... Grant entitled "Adult Stem Cell Minimally Invasive Bone ... MarrowMiner(TM) which,recently received 510(k) clearance from the U.S. ...
... 2008 - A team of five University of Akron ... role of temperature and humidity in PLoS ONE, an ... , The UA authors are Dr. Peter Niewiarowski, professor ... Ge, graduate assistant in polymer science; Emily Hagan (undergraduate ...
... Flow Cytometry Platforms, FRANKLIN LAKES, N.J., May 13 ... announced today that it has acquired all,of the outstanding ... Seattle that develops and markets advanced flow,cytometry cell sorting ... disclosed. The acquisition,is not expected to have a material ...
Cached Biology Technology:StemCor Systems, Inc. Awarded NIH SBIR Grant for Bone Marrow Aspiration Platform 2StemCor Systems, Inc. Awarded NIH SBIR Grant for Bone Marrow Aspiration Platform 3BD Announces Acquisition of Cytopeia 2BD Announces Acquisition of Cytopeia 3
(Date:8/31/2014)... Warwick have discovered that ,good, cholesterol is turned ,bad, ... - MG, was found to damage ,good, HDL cholesterol, ... body. , Low levels of HDL, High Density ... levels of MG being common in the elderly and ... by funding from the British Heart Foundation (BHF) and ...
(Date:8/31/2014)... busy attacking us, germs go after each other. But ... for the infected microbes: Sometimes viruses actually carry helpful ... its diet or better attack its own hosts. , ... system would robotically destroy anything it recognized as invading ... now revealed that one variety of the bacterial immune ...
(Date:8/31/2014)... French . Montral, ... prestigious Nature Neuroscience journal by, Sylvain Williams, PhD, ... Mental Health University Institute and McGill University, opens the door ... controlling memory as well of the role of an essential ... , In 2009, they developed a unique approach ...
Breaking Biology News(10 mins):Sugar substance 'kills' good HDL cholesterol, new research finds 2Discovery reveals how bacteria distinguish harmful vs. helpful viruses 2Discovery reveals how bacteria distinguish harmful vs. helpful viruses 3Memory and Alzheimer's: Towards a better comprehension of the dynamic mechanisms 2
... can greatly impact biological species and ecosystems, requiring ... accommodate habitat shifts. Recorded data already show ... regions where their climatic requirements are better met. ... regulators on climate change implications for local conservation, ...
... continue to be energy-intensive and highly polluting for the foreseeable ... the agenda, according to a study published in the ... Xia of Dongbei University of Finance and Economics and the ... has looked at almost a decade,s worth of data from ...
... in the Department of Chemistry and Biochemistry at the ... Career Development Award from the National Science Foundation (NSF) ... to study the biophysics of model cell membranes, with ... will support the purchase of a computer cluster for ...
Cached Biology News:Workshop to focus on conservation management and climate change 2Polluting China for the sake of economic growth 2Patel recognized with NSF Career Award for computer-modeling research on cell membranes 2Patel recognized with NSF Career Award for computer-modeling research on cell membranes 3
EnzChek Ultra Xylanase Assay Kit *500 assays*...
Goat polyclonal to p27 KIP 1 ( Abpromise for all tested applications). Antigen: Synthetic peptide: C-KRPATDDS STQNK, corresponding to Internal sequence amino acids 153-165 of Human p27 KIP 1 ...
Defender against cell death 1...
Wnt-1 (G-19)...
Biology Products: